IMPACT

Serial Number 99138400
661

Registration Progress

Application Filed
Apr 15, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Attorney Assistance

Non-Final Action E-Mailed
Due: Jul 30, 2025 13 days

Trademark Image

IMPACT

Basic Information

Serial Number
99138400
Filing Date
April 15, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
661
Status Date
Jul 2, 2025
Application
Pending
Classes
005 010 042

Rights Holder

RAIN Scientific, Inc.

03
Address
20830 Torrence Chapel Rd., Suite 206
Cornelius, NC 28031

Ownership History

RAIN Scientific, Inc.

Original Applicant
03
Cornelius, NC

Legal Representation

Attorney
Kristen Ruisi

USPTO Deadlines

Next Deadline
13 days remaining
Non-Final Action E-Mailed
Due Date
July 30, 2025
Extension Available
Until October 30, 2025

Application History

10 events
Date Code Type Description Documents
Jul 2, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 2, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 2, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 30, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 30, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 30, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 30, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 15, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 15, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Apr 15, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of blood-borne pathogens and diseases caused thereby; pharmaceutical preparations for the treatment of viruses, bacteria and other pathogenic organisms and diseases caused thereby
Class 010
Medical devices for use in treating infections caused by antimicrobial resistant microorganisms; medical devices for use in treating sepsis
Class 042
Providing medical and scientific research information in the field of health and pharmaceuticals on the internet; Research and development of new products for others; Research and development services, namely conducting research focused on the fight against antimicrobial resistance (AMR) and for the treatment of blood-borne pathogens and diseases

Classification

International Classes
005 010 042